1832 Asset Management
INSP icon

1832 Asset Management’s Inspire Medical Systems INSP Stock Holding History

1832 Asset Management’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-8,100
Closed -$1.74M – 930
2024
Q1 		$1.74M Buy
+8,100
New +$1.59M ﹤0.01% 528
2023
Q4 		– Sell
-562,400
Closed -$112M – 876
2023
Q3 		$112M Buy
562,400
+229,500
+69% +$57.9M 0.16% 99
2023
Q2 		$108M Buy
332,900
+148,400
+80% +$42.4M 0.13% 96
2023
Q1 		$43.2M Buy
+184,500
New +$46.6M 0.06% 198

Other funds holding INSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

1832 Asset Management's INSP Position: Q2 2024 in Review

1832 Asset Management sold out of Inspire Medical Systems (INSP) in Q2 2024, closing a stake of 8,100 shares — an estimated $1.74M sold.

1832 Asset Management first reported a position in INSP in Q1 2023 and held it in 4 quarters. The position peaked at $112M in Q3 2023. 325 funds tracked by Wall St. Rank hold INSP as of Q2 2024.

  • 1832 Asset Management reported no remaining Inspire Medical Systems position as of Q2 2024 after selling out during the quarter.
  • 1832 Asset Management sold 8,100 Inspire Medical Systems shares in Q2 2024, an estimated $1.74M.
  • 1832 Asset Management first reported a position in Inspire Medical Systems in Q1 2023 and held it in 4 quarters.
  • 1832 Asset Management's Inspire Medical Systems position peaked at $112M in Q3 2023.
  • 325 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2024.

Based on 1832 Asset Management's 13F filing for Q2 2024, filed 13 Aug 2024.